State Of Wisconsin Investment Board Tcr2 Therapeutics Inc. Transaction History

State Of Wisconsin Investment Board

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$4.58 - $8.34 $163,506 - $297,738	-35,700 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$8.44 - $18.35 $92,840 - $201,850	-11,000 Reduced 23.55%	35,700 $304,000
Q2 2021 Aug 12, 2021	SELL	$16.41 - $24.71 $50,871 - $76,601	-3,100 Reduced 6.22%	46,700 $766,000
Q1 2021 May 17, 2021	BUY	$20.38 - $34.07 $59,102 - $98,803	2,900 Added 6.18%	49,800 $1.1 Million
Q4 2020 Feb 03, 2021	BUY	$19.0 - $32.63 $64,600 - $110,942	3,400 Added 7.82%	46,900 $1.45 Million

Q3 2020 Nov 16, 2020	BUY	$13.1 - $20.69 $569,850 - $900,015	43,500 New	43,500 $884,000

Ticker TCRR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,606,400
Description
TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. The company's lead product candidates include gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which is in phase I/II clinical tria...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.